LESLIE STEFANOWICZ: Open Payments
NPI 1639159783 · BROCKTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,319 in 185 payments from 22 companies in 2025. Trend: 2023 $27,218 · 2024 $15,058 · 2025 $7,319
Food & beverage: $4,144Speaker / faculty: $2,030Consulting: $1,050Education: $96
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 24 | $3,634 |
| AstraZeneca Pharmaceuticals LP | 36 | $1,164 |
| GlaxoSmithKline, LLC. | 14 | $340 |
| GENZYME CORPORATION | 9 | $263 |
| LEO Pharma Inc. | 10 | $244 |
| Novartis Pharmaceuticals Corporation | 15 | $243 |
| PFIZER INC. | 12 | $230 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $200 |
| CSL Behring | 11 | $194 |
| Genentech USA, Inc. | 16 | $184 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, FASENRA, TUDORZA PRESSAIR, ADBRY, AIRSUPRA, OCTAGAM IMMUNE GLOBULIN (HUMAN).
Industry payments across MA — which companies pay providers there.
